Drug-Eluting Stent Shows Similar Patency Results as Prosthetic Bypass in Patients with Femoropopliteal Occlusion in a Randomized Trial

Annals of Vascular Surgery

Volumn 53, Issue , 2018, Pages 165-170

  Björkman, Patrick ^a   Auvinen, Tommi ^b   Hakovirta, Harri ^c   Romsi, Pekka ^d   Turtiainen, Johanna ^e   Manninen, Hannu ^b   Venermo, Maarit ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e Joensuu Central Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; POLITEF; WARFARIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY OCCLUSION; ARTICLE; CLAUDICATION; CLINICAL ARTICLE; CLINICAL OUTCOME; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; FEMOROPOPLITEAL OCCLUSION; FINLAND; FOLLOW UP; GRAFT PATENCY; HUMAN; LEG AMPUTATION; LOW DRUG DOSE; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC BYPASS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SUPERFICIAL FEMORAL ARTERY; SURVIVAL; AMPUTATION; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; GRAFT OCCLUSION; LIMB SALVAGE; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSTHESIS DESIGN; TIME FACTOR; TREATMENT OUTCOME; VASCULAR PATENCY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMPUTATION; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; FINLAND; GRAFT OCCLUSION, VASCULAR; HUMANS; LIMB SALVAGE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROGRESSION-FREE SURVIVAL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 85049476555     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2018.04.014     Document Type: Article

References (21)

1. Wolfe, J., Wyatt, M., Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 13 (1997), 578–582.
2. Norgren, L., Hiatt, W.R., Dormandy, J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33 (2007), S1–S75.
3. Jensen, S.A., Vatten, L.J., Romundstad, P.R., et al. The prevalence of intermittent claudication. Sex-related differences have been eliminated. Eur J Vasc Endovasc Surg 25 (2003), 209–212.
4. Dormandy, J.A., Murray, G.D., Reprinted article “the fate of the claudicant—a prospective study of 1969 claudicants”. Eur J Vasc Endovasc Surg 42 (2011), S4–S6.
5. Klinkert, P., Post, P.N., Breslau, P.J., et al. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 27 (2004), 357–362.
6. Garg, K., Kaszubski, P.A., Moridzadeh, R., et al. Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia. J Vasc Surg 59 (2014), 392–399.
7. Bradbury, A.W., Adam, D.J., Bell, J., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 51 (2010), 18S–31S.
8. Nolan, B.W., De Martino, R.R., Stone, D.H., et al. Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg 54 (2011), 730–735.
9. McQuade, K., Gable, D., Pearl, G., et al. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 52 (2010), 584–590.
10. Linnakoski, H., Uurto, I., Suominen, V., et al. Comparison of above-the-knee prosthetic femoro-popliteal bypass versus percutaneous transluminal angioplasty and stenting for treatment of occlusive superficial femoral artery disease. Scand J Surg 102 (2013), 227–233.
11. Windecker, S., Remondino, A., Eberli, F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005), 653–662.
12. Duda, S.H., Bosiers, M., Lammer, J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16 (2005), 331–338.
13. Lammer, J., Bosiers, M., Zeller, T., et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 54 (2011), 394–401.
14. Dake, M.D., Ansel, G.M., Jaff, M.R., et al., Zilver PTX Investigators. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation 133 (2016), 1472–1483.
15. Axel, D.I., Kunert, W., Göggelmann, C., et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96 (1997), 636–645.
16. Stettler, C., Wandel, S., Allemann, S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007), 937–948.
17. Abal, M., Barasoain, J.M., Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action. Curr Cancer Drug Targets 3 (2003), 193–203.
18. Horwitz, S., Cohen, D., Rao, S., et al. Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr 15 (1993), 55–61.
19. Dake, M.D., Ansel, G.M., Jaff, M.R., et al., Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 61 (2013), 2417–2427.
20. Lepantalo, M., Laurila, K., Roth, W.D., et al., Scandinavian Thrupass Study Group. PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial. Eur J Vasc Endovasc Surg 37 (2009), 578–584.
21. Kedora, J., Hohmann, S., Garrett, W., et al. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 45 (2007), 10–16.